Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies
Open Access
- 3 March 2021
- Vol. 9 (3), 214
- https://doi.org/10.3390/vaccines9030214
Abstract
Since the emergence of SARS-CoV-2 at the end of 2019, 64 candidate vaccines are in clinical development and 173 are in the pre-clinical phase. Five types of vaccines are currently approved for emergency use in many countries (Inactivated, Sinopharm; Viral-vector, Astrazeneca, and Gamaleya Research Institute; mRNA, Moderna, and BioNTech/Pfizer). The main challenge in this pandemic was the availability to produce an effective vaccine to be distributed to the world’s population in a short time. Herein, we developed a whole virus NRC-VACC-01 inactivated candidate SARS-CoV-2 vaccine and tested its safety and immunogenicity in laboratory animals. In the preclinical studies, we used four experimental animals (mice, rats, guinea pigs, and hamsters). Antibodies were detected as of week three post vaccination and continued up to week ten in the four experimental models. Safety evaluation of NRC-VACC-01 inactivated candidate vaccine in rats revealed that the vaccine was highly tolerable. By studying the effect of booster dose in the immunological profile of vaccinated mice, we observed an increase in neutralizing antibody titers after the booster shot, thus a booster dose was highly recommended after week three or four. Challenge infection of hamsters showed that the vaccinated group had lower morbidity and shedding than the control group. A phase I clinical trial will be performed to assess safety in human subjects.Funding Information
- National Research Centre (MP120810)
- National Institute of Allergy and Infectious Diseases (HHSN272201400006C)
This publication has 27 references indexed in Scilit:
- The Immune System in Tissue Environments Regaining Homeostasis after Injury: Is “Inflammation” Always Inflammation?Mediators of Inflammation, 2016
- Comparison ofβ-Propiolactone and Formalin Inactivation on Antigenicity and Immune Response of West Nile VirusAdvances in Virology, 2015
- Comparison of ketamine-xylazine and ketamine-dexmedetomidine anesthesia and intraperitoneal tolerance in rats.2013
- Influenza vaccination and hemostasis: no sustainable procoagulant effects from 2009 H1N1 influenza vaccine in healthy healthcare workersJournal of Thrombosis and Haemostasis, 2011
- Immunogenicity and Protective Efficacy in Mice and Hamsters of a β-Propiolactone Inactivated Whole Virus SARS-CoV VaccineViral Immunology, 2010
- Fever following immunizationExpert Review of Vaccines, 2005
- Diagnostic Value of Blood D-dimer Level in Acute Mesenteric Ischaemia in the Rat: An Experimental StudyAsian Journal of Surgery, 2005
- Fever after Immunization: Current Concepts and Improved Future Scientific UnderstandingClinical Infectious Diseases, 2004
- Acute inflammatory response and remodeling of airway epithelium after subspecies B1 human adenovirus infection of the mouse lower respiratory tractJournal of Medical Virology, 2003
- D-dimer testing in the diagnosis of acute venous thromboembolism.1999